Adrian Gottschalk Foghorn Therapeutics Inc. (FHTX) insider trading activity

FHTX Quotes by TradingView

Adrian Gottschalk is Chief Executive Officer of Foghorn Therapeutics Inc.. Currently has a direct ownership of 0 shares of FHTX, which is worth approximately $0. The most recent transaction as insider was on Aug 17, 2023, when has been sold 63,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

ADRIAN GOTTSCHALK Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 17 2023
SELL
Bona fide gift
-
63,000 Reduced 100.0%
0 Common Stock
Feb 17 2023
SELL
Bona fide gift
-
4,371 Reduced 6.49%
63,000 Common Stock
Oct 25 2022
BUY
Other acquisition or disposition
-
4,371 Added 6.09%
67,371 Common Stock
Sep 16 2022
BUY
Exercise of conversion of derivative security
$21,600 $0.54 p/Share
40,000 Added 17.66%
186,479 Common Stock
Feb 10 2022
SELL
Bona fide gift
-
123,479 Reduced 84.3%
23,000 Common Stock
Aug 20 2021
BUY
Exercise of conversion of derivative security
$12,420 $0.54 p/Share
23,000 Added 4.9%
446,479 Common Stock
AG

Adrian Gottschalk

Chief Executive Officer
Cambridge, MA

Track Institutional and Insider Activities on FHTX

Follow Foghorn Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FHTX shares.

Notify only if

Insider Trading

Get notified when an Foghorn Therapeutics Inc. insider buys or sells FHTX shares.

Notify only if

News

Receive news related to Foghorn Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on FHTX